Journals / Türk Kardiyoloji Derneği Arşivi / 2019 / Cilt: 47 - Sayı: 3

Prediction of new onset atrial fibrillation in patients with acute pulmonary embolism: The role of sPESI Score

Akut pulmoner emboli hastalarında yeni gelişen atriyal fibrilasyon öngörücülüğü: sPESI Skoru’nun rolü

Pages
191–197
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

New-AF patients demonstrated larger LVEDD and LADdimensions (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Acute pulmonary embolism (APE) is a seriousclinical situation and atrial fibrillation (AF) is the most commonarrhytmia in clinical practice.
📊
Key Findings & Data:The aim of thisstudy was to evaluate the relationship between the PESIscore and new-onset AF in patients with APE.Methods: The records of 869 APE patients admitted betweenMay 2012 and December 2015 were evaluated retrospectively.The PESI score was calculated for every patient.
💡
Conclusion & Impact:New-AF patients demonstrated larger LVEDD and LADdimensions (p
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Acute pulmonary embolism (APE) is a seriousclinical situation and atrial fibrillation (AF) is the most commonarrhytmia in clinical practice. The Pulmonary EmbolismSeverity Index (PESI) is an accepted risk stratification toolused to predict short term mortality in APE. The aim of thisstudy was to evaluate the relationship between the PESIscore and new-onset AF in patients with APE.Methods: The records of 869 APE patients admitted betweenMay 2012 and December 2015 were evaluated retrospectively.The PESI score was calculated for every patient. Clinical variablesassociated with new-onset AF in APE were assessedafter the exclusion of patients with hypertension, coronary orhemodynamically significant valvular heart disease, hepaticor renal dysfunction, chronic obstructive pulmonary disease,thyroid dysfunction, diabetes mellitus, sleep apnea, any historyof inflammatory or infectious disease, or recent trauma.New-onset AF was detected in 42 (4.8%) patients.Results: Age, gender, systolic and diastolic blood pressure,heart rate, fasting glucose level, serum creatinine, left ventricleejection fraction, tricuspid annular plane systolic excursionvalue, and pulmonary artery systolic pressure measures werenot significantly different between patients with and withoutAF. New-AF patients demonstrated larger LVEDD and LADdimensions (p

Özet

Amaç: Akut pulmoner emboli (APE) ciddi bir klinik durumdur ve atriyal fibrilasyon (AF) klinik pratikte en sık görülen aritmidir. Pulmoner Emboli Ciddiyet İndeksi (PESI) APE’de kısa dönem mortaliteyi öngören skorlama sistemidir. Bu çalışmada, APE’li hastalarda PESI skoru ile yeni gelişen AF ilişkisini bulmayı amaçladık. Yöntemler: Mayıs 2012 ile Aralık 2015 arasında başvuran 869 hastanın bilgileri geriye dönük olarak değerlendirildi. Tüm hastaların PESI skorları hesaplandı. Hipertansiyon, koroner veya yapısal kalp hastalığı, hepatik veya böbrek disfonksiyon, kronik obstrüktif akciğer hastalığı, tiroit disfonksiyon, diyabet veya uyku apne, enflamatuvar veya enfeksiyon hastalığı öyküsü, yeni travma veya cerrahi, steroid veya nonsteroid enflamatuvar ilaç kullanımı bulunan hastalar dışlandı. Kırk iki (%4.8) yeni-AF’li hasta dahil edildi. Bulgular: Yaş, cinsiyet, sistolik ve diyastolik kan basıncı, kalp hızı, açlık glikoz düzeyi, serum kreatinin, sol ventrikül ejeksiyon fraksiyonu, trikuspit anüler düzlem hareket değeri ve pulmoner arter sistolik basınç ölçümleri AF olan ve olmayan hastalar arasında anlamlı farklılık göstermedi (p >0.05). Yeni-AF hastalarında daha uzun LVEDD ve LAD değerleri mevcuttu (p

🔖

Cite This Article

Şahan, E., TÜFEKÇİOĞLU, O., KARAMANLIOĞLU, M., ŞAHAN, S. (2022). Prediction of new onset atrial fibrillation in patients with acute pulmonary embolism: The role of sPESI Score. Türk Kardiyoloji Derneği Arşivi, Cilt: 47 - Sayı: 3, 191–197. https://ajindex.com/articles/632069

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999;353:1386–9
  2. Aujesky D, Obrosky DS, Stone RA, Auble TE, Perrier A, Cornuz J, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 2005;172:1041–6
  3. Jiménez D, Aujesky D, Moores L, Gómez V, Lobo JL, Uresandi F, et al.; RIETE Investigators. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. ArchIntern Med 2010;170:1383–9
  4. Haim M, Hoshen M, Reges O, Rabi Y, Balicer R, Leibowitz M. Prospective national study of the prevalence, incidence, management and outcome of a large contemporary cohort of patients with incident non-valvular atrial fibrillation. J Am Heart Assoc 2015;4:e001486
  5. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace 2016;18:1609–78
  6. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al.; Chamber Quantification Writing Group; American Society of Echocardiography’s Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440–63
  7. Hald EM, Enga KF, Løchen ML, Mathiesen EB, Njølstad I, Wilsgaard T, et al. Venous thromboembolism increases the risk of atrial fibrillation: the Tromso study. J Am Heart Assoc 2014;3:e000483
  8. Zhang CH, Huang DS, Shen D, Zhang LW, Ma YJ, Wang YM, et al. Association Between Serum Uric Acid Levels and Atrial Fibrillation Risk. Cell Physiol Biochem 2016;38:1589–95
  9. Kawasoe S, Kubozono T, Yoshifuku S, Ojima S, Oketani N, Miyata M, et al. Uric Acid Level and Prevalence of Atrial Fibrillation in a Japanese General Population of 285,882. Circ J 2016;80:2453–9
  10. Ng AC, Adikari D, Yuan D, Lau JK, Yong AS, Chow V, et al. The Prevalence and Incidence of Atrial Fibrillation in Patients with Acute Pulmonary Embolism. PLoS One 2016;11:e0150448
  11. Hijazi Z, Oldgren J, Siegbahn A, Wallentin L. Application of Biomarkers